Free Newsletter
U.K. approves 'cybrids' for stem cell research
In the interest of making more and better human stem cells for research, U.K. regulators have approved the creation of short-lived human/animal hybrid embryos. Only tiny fragments of animal DNA will be used, they say, and no freaks of nature will be unleashed. These will be the first human/animal embryos allowed for research. The first cytoplasmic hybrid embryos--dubbed cybrids--should be created by the end of the year. There's still a chance that opponents could block the move in court.
Several research teams have been seeking permission to create cybrids for work on Alzheimer's and Parkinson's. Another team focused on motor neuron disease is also expected to file for approval as well.
- read the statement on the decision
- see the Times report
Related Article:
Human/animal chimeras get a reprieve in the U.K. Report
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: